The effects of sildenafil on lung function in COPD Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD Year: 2012
Effect of smoking on lung functions in patients with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 157s Year: 2005
The effect of leukotrienes receptor antagonists on lung function, exercise tolerance and incidence of exacerbations in patients with stable, moderate COPD Source: Eur Respir J 2002; 20: Suppl. 38, 620s Year: 2002
Bronchodilator response of advanced lung function parameters depending on COPD severity Source: International Congress 2016 – Functional assessment of the airways Year: 2016
The effect of different bronchodilator drugs on pulmonary function tests, exercise capacity and quality of life in patients with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 515s Year: 2005
The pharmacogenomics of inhaled corticosteroids and lung function decline in COPD Source: Eur Respir J, 54 (6) 1900521; 10.1183/13993003.00521-2019 Year: 2019
Comparison of protective effect of bronchodilators in COPD Source: International Congress 2015 – Safety of and interactions between current treatments for asthma and COPD Year: 2015
Effect of dual bronchodilation with indacaterol/glycopirronium on small airways resistance in patients with stable COPD Source: International Congress 2016 – Non-inflammatory COPD monitoring Year: 2016
Anti-inflammatory effects of targeted lung denervation in patients with COPD Source: Eur Respir J 2015; 46: 1489-1492 Year: 2015
Estimating lung function decline and the effect of smoking in COPD patients Source: Eur Respir J 2002; 20: Suppl. 38, 578s Year: 2002
The effects of bronchodilators on regional lung sound distribution in patients with COPD Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation Year: 2013
Predictors of lung function deterioration in COPD Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016
ß2 -adrenoceptor modulation in COPD and its potential impact on cardiovascular comorbidities Source: Eur Respir Monogr 2020; 88: 229-237 Year: 2020
Irisin is associated with severe exacerbations of COPD independently of lung function, comorbidities and exercise capacity Source: International Congress 2015 – Notable abstracts in COPD: variety Year: 2015
The relationship of exacerbations and lung function decline to radiologic characteristics in COPD Source: Eur Respir J 2005; 26: Suppl. 49, 512s Year: 2005
The effect of obesity on lung function Source: Annual Congress 2013 –Clinical respiratory physiology in different diseases Year: 2013
Does atorvastatin have effect on lung function and morbidity as add-on therapy in asthmatic patients? Source: Annual Congress 2007 - New drugs for asthma Year: 2007
Which lung function variables are the most sensitive to a short bronchodilator in COPD patients? Source: Annual Congress 2008 - Quality spirometry: the only spirometry! Year: 2008
The positive effect of cilomilast on lung function in patients with chronic obstructive pulmonary disease (COPD) is independent of patient smoking status Source: Eur Respir J 2002; 20: Suppl. 38, 620s Year: 2002
The effects of combined COPD and obesity on lung volumes and respiratory mechanics during exercise Source: Annual Congress 2009 - New developments in exercise physiology Year: 2009